Doping Control Analysis of Bovine Hemoglobin-Based Oxygen Therapeutics in Human Plasma by LC-Electrospray Ionization-MS/MS
详细信息    查看全文
文摘
Since January 2000, hemoglobin-based oxygen carriers,such as Hemopure, belong to the list of prohibitedsubstances of the International Olympic Committee. Hemopure is based on bovine hemoglobin, which is intra-and intermolecularly cross-linked by glutaraldehyde unitscausing an average molecular weight of ~250 000. Bovineand human hemoglobins differ by 15% in amino acidsequence; hence, tryptic digestion of these proteinsgenerates species-common and -unique peptides. Thosespecific fragments originate from the - and -subunitsof hemoglobin, such as bovine Hb peptides 69-90 (2367.2Da) or 40-58 (2089.9 Da). By means of LC-MS/MS,peptides of human and bovine hemoglobin can be separated and identified, enabling the determination of compounds based on Hb of bovine origin and thus theadministration of oxygen carriers such as Hemopure.Blank plasma samples were spiked with Hemopure orhuman or bovine hemoglobin, filtered, enzymaticallydigested, and analyzed on an Agilent 1100 Series HPLCinterfaced to an Applied Biosystems API 2000 triplequadrupole mass spectrometer. In plasma aliquots of 50L containing 50 g of Hemopure (1 mg/mL), peptidesof bovine hemoglobin were confirmed, and blank plasmasamples as well as 68 specimens of high-performanceathletes were tested with the developed procedure.

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700